Bacil Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 0.56 | 0.01 | 0.02 |
| Operating Expense | 0.07 | 0.04 | 0.06 |
| Net Profit | 0.48 | -0.03 | -0.04 |
| Net Profit Margin | 85.71 | -300 | -200 |
| Earning Per Share | 0.82 | -0.06 | -0.07 |
| EBIDTA | 0.48 | -0.03 | -0.04 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 0.56 |
| Operating Expense | 0.07 |
| Net Profit | 0.48 |
| Net Profit Margin | 85.71 |
| Earning Per Share | 0.82 |
| EBIDTA | 0.48 |
| Effective Tax Rate | TBA |
Invest in Bacil Pharma Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | TBA | TBA | TBA |
| Operating Expenses Annual | 0.19 | 0.21 | 3.91 |
| Operating Profit Annual | -0.06 | -0.10 | -3.86 |
| Interest Annual | TBA | TBA | TBA |
| Depreciation | 0.00 | 0.00 | 0.00 |
| Net Profit Annual | -0.06 | -0.10 | -3.86 |
| Tax Annual | 0.00 | -0.00 | -0.00 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | TBA |
| Operating Expenses Annual | 0.19 |
| Operating Profit Annual | -0.06 |
| Interest Annual | TBA |
| Depreciation | 0.00 |
| Net Profit Annual | -0.06 |
| Tax Annual | 0.00 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.03 | 0.23 | 0.10 |
| Cash Flow from Operations | TBA | -0.15 | -4.01 |
| Cash Flow from Investing | 0.08 | -0.12 | 3.81 |
| Cash Flow from Financing | -0.06 | 0.06 | 0.33 |
| Cash Flow at the End | 0.04 | 0.03 | 0.23 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.03 |
| Cash Flow from Operations | TBA |
| Cash Flow from Investing | 0.08 |
| Cash Flow from Financing | -0.06 |
| Cash Flow at the End | 0.04 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | TBA | TBA | TBA |
| PBIT Margin (%) | TBA | TBA | TBA |
| PBT Margin (%) | TBA | TBA | TBA |
| Net PROFIT Margin (%) | TBA | TBA | TBA |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | TBA | TBA | TBA |
| Total Debt / Equity (X) | 0.05 | 0.02 | 0.08 |
| Asset Turnover Ratio (%) | TBA | TBA | TBA |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | TBA |
| PBIT Margin (%) | TBA |
| PBT Margin (%) | TBA |
| Net PROFIT Margin (%) | TBA |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | TBA |
| Total Debt / Equity (X) | 0.05 |
| Asset Turnover Ratio (%) | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 0.01 | 0.01 | 0.01 |
| Total Current Assets Annual | 0.05 | 0.23 | 0.32 |
| Non Current Assets Annual | 1.27 | 0.90 | 0.96 |
| Total Shareholders Funds Annual | 1.21 | 1.10 | 1.22 |
| Total Assets Annual | 1.33 | 1.13 | 1.27 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 0.01 |
| Total Current Assets Annual | 0.05 |
| Non Current Assets Annual | 1.27 |
| Total Shareholders Funds Annual | 1.21 |
| Total Assets Annual | 1.33 |
No Data Availabe
